These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 17331069)

  • 1. Targeting and intracellular trafficking of clinically relevant hTHTR1 mutations in human cell lines.
    Subramanian VS; Marchant JS; Said HM
    Clin Sci (Lond); 2007 Jul; 113(2):93-102. PubMed ID: 17331069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The gene mutated in thiamine-responsive anaemia with diabetes and deafness (TRMA) encodes a functional thiamine transporter.
    Fleming JC; Tartaglini E; Steinkamp MP; Schorderet DF; Cohen N; Neufeld EJ
    Nat Genet; 1999 Jul; 22(3):305-8. PubMed ID: 10391222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations in SLC19A2 cause thiamine-responsive megaloblastic anaemia associated with diabetes mellitus and deafness.
    Labay V; Raz T; Baron D; Mandel H; Williams H; Barrett T; Szargel R; McDonald L; Shalata A; Nosaka K; Gregory S; Cohen N
    Nat Genet; 1999 Jul; 22(3):300-4. PubMed ID: 10391221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in a new gene encoding a thiamine transporter cause thiamine-responsive megaloblastic anaemia syndrome.
    Diaz GA; Banikazemi M; Oishi K; Desnick RJ; Gelb BD
    Nat Genet; 1999 Jul; 22(3):309-12. PubMed ID: 10391223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thiamine-responsive megaloblastic anaemia syndrome: long-term follow-up and mutation analysis of seven families.
    Ricketts CJ; Minton JA; Samuel J; Ariyawansa I; Wales JK; Lo IF; Barrett TG
    Acta Paediatr; 2006 Jan; 95(1):99-104. PubMed ID: 16373304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell biology of the human thiamine transporter-1 (hTHTR1). Intracellular trafficking and membrane targeting mechanisms.
    Subramanian VS; Marchant JS; Parker I; Said HM
    J Biol Chem; 2003 Feb; 278(6):3976-84. PubMed ID: 12454006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The spectrum of mutations, including four novel ones, in the thiamine-responsive megaloblastic anemia gene SLC19A2 of eight families.
    Raz T; Labay V; Baron D; Szargel R; Anbinder Y; Barrett T; Rabl W; Viana MB; Mandel H; Baruchel A; Cayuela JM; Cohen N
    Hum Mutat; 2000; 16(1):37-42. PubMed ID: 10874303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel mutation in the SLC19A2 gene in a Turkish male with thiamine-responsive megaloblastic anemia syndrome.
    Odaman-Al I; Gezdirici A; Yıldız M; Ersoy G; Aydoğan G; Şalcıoğlu Z; Tahtakesen TN; Önal H; Küçükemre-Aydın B
    Turk J Pediatr; 2019; 61(2):257-260. PubMed ID: 31951336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel mutation in the SLC19A2 gene in a Turkish male with thiamine-responsive megaloblastic anemia syndrome.
    Odaman-Al I; Gezdirici A; Yıldız M; Ersoy G; Aydoğan G; Şalcıoğlu Z; Tahtakesen TN; Önal H; Küçükemre-Aydın B
    Turk J Pediatr; 2019; 61(2):257-260. PubMed ID: 31951337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recessive SLC19A2 mutations are a cause of neonatal diabetes mellitus in thiamine-responsive megaloblastic anaemia.
    Shaw-Smith C; Flanagan SE; Patch AM; Grulich-Henn J; Habeb AM; Hussain K; Pomahacova R; Matyka K; Abdullah M; Hattersley AT; Ellard S
    Pediatr Diabetes; 2012 Jun; 13(4):314-21. PubMed ID: 22369132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thiamine-responsive megaloblastic anaemia: a cause of syndromic diabetes in childhood.
    Olsen BS; Hahnemann JM; Schwartz M; Østergaard E
    Pediatr Diabetes; 2007 Aug; 8(4):239-41. PubMed ID: 17659067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional role of specific amino acid residues in human thiamine transporter SLC19A2: mutational analysis.
    Balamurugan K; Said HM
    Am J Physiol Gastrointest Liver Physiol; 2002 Jul; 283(1):G37-43. PubMed ID: 12065289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Defect of thiamine transport and activation and related disease].
    Xian X; Lin F
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2018 Feb; 35(1):121-124. PubMed ID: 29419877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thiamine-responsive megaloblastic anemia syndrome: a disorder of high-affinity thiamine transport.
    Neufeld EJ; Fleming JC; Tartaglini E; Steinkamp MP
    Blood Cells Mol Dis; 2001; 27(1):135-8. PubMed ID: 11358373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First 2 cases with thiamine-responsive megaloblastic anemia in the Czech Republic, a rare form of monogenic diabetes mellitus: a novel mutation in the thiamine transporter SLC19A2 gene-intron 1 mutation c.204+2T>G.
    Pomahačová R; Zamboryová J; Sýkora J; Paterová P; Fiklík K; Votava T; Černá Z; Jehlička P; Lád V; Šubrt I; Dort J; Dortová E
    Pediatr Diabetes; 2017 Dec; 18(8):844-847. PubMed ID: 28004468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leber's congenital amaurosis as the retinal degenerative phenotype in thiamine responsive megaloblastic anemia: a case report.
    Srikrupa NN; Meenakshi S; Arokiasamy T; Murali K; Soumittra N
    Ophthalmic Genet; 2014 Jun; 35(2):119-24. PubMed ID: 23638917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thiamine-responsive megaloblastic anemia: early diagnosis may be effective in preventing deafness.
    Onal H; Bariş S; Ozdil M; Yeşil G; Altun G; Ozyilmaz I; Aydin A; Celkan T
    Turk J Pediatr; 2009; 51(3):301-4. PubMed ID: 19817279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of plasma membrane targeting of a G172D mutant thiamine transporter derived from Rogers syndrome family.
    Baron D; Assaraf YG; Cohen N; Aronheim A
    Mol Med; 2002 Aug; 8(8):462-74. PubMed ID: 12435857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infantile-onset thiamine responsive megaloblastic anemia syndrome with SLC19A2 mutation: a case report.
    Katipoğlu N; Karapinar TH; Demir K; Aydin Köker S; Nalbantoğlu Ö; Ay Y; Korkmaz HA; Oymak Y; Yıldız M; Tunç S; Hazan F; Vergin C; Ozkan B
    Arch Argent Pediatr; 2017 Jun; 115(3):e153-e156. PubMed ID: 28504500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biotin-responsive basal ganglia disease-linked mutations inhibit thiamine transport via hTHTR2: biotin is not a substrate for hTHTR2.
    Subramanian VS; Marchant JS; Said HM
    Am J Physiol Cell Physiol; 2006 Nov; 291(5):C851-9. PubMed ID: 16790503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.